跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,169 条关于
“Dominari Securities”
全部
1,169
临床试验
323
药物
8
机构
19
资讯
819
去年
Persanta Advances Towards IPO with Dominari Securities to Commercialize Early Cancer Detection Technology
去年
Jupiter Neurosciences Raises $11 Million in IPO to Advance Parkinson's Drug
去年
Vertex Pharmaceuticals Faces Securities Fraud Investigation After Disappointing Suzatrigine Trial Results
去年
Serina Therapeutics and enVVeno Medical Each File $100M Mixed Securities Shelf
去年
Iovance CFO Resigns Amid Amtagvi Launch Struggles and Securities Fraud Investigation
去年
Alnylam's Amvuttra Poised to Become First-Line ATTR-CM Treatment
去年
Agios Pharmaceuticals Faces Securities Fraud Investigation Following FDA Delay of PYRUKYND Approval
去年
Click Therapeutics Highlights PDURS Potential to Revolutionize Digital Therapeutics
去年
Cassava Sciences Faces Class Action Lawsuit After Simufilam Fails Phase 3 Trial
去年
NLS Pharmaceutics and NewAmsterdam Pharma File Mixed Securities Shelves Worth $75M and $500M Respectively
第 1 页,共 82 页
上一页
下一页